Home > PJ (current issue) > The Society | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 268 No 7182 p115
26 January 2002

The Society

 Law and Ethics Bulletin

An occasional feature, prepared in the Royal Pharmaceutical Society's Professional Standards Directorate, to highlight problems and inquiries currently being handled


The Misuse of Drugs Regulations 2001

The Misuse of Drugs Regulations 2001, which come into effect on 1 February, are a consolidation of the Misuse of Drugs Regulations 1985 and its subsequent amendments. They are almost identical in terms to the 1985 Regulations and therefore there is little change for pharmacists in hospital or community practice.

Benzodiazepines (and eight other substances) and anabolic drugs were listed in Part II and Part I, respectively, of Schedule 4 of the 1985 Regulations. These were commonly referred to as CD (Benz) and CD (Anab) for simplicity. Changes have now been made to reverse the listing, so that Part I becomes Part II and vice versa. There is no need to change the descriptions, although the effect is that CD (Benz) now means Schedule 4 Part I. This change was accompanied by a tightening of the controls on benzodiazepine drugs, so that the degree of control now moves progressively through the Schedules, with Schedule 1 being the most stringent and Schedule 5 the least stringent.

The new controls on benzodiazepines include restrictions on import and export, and possession without authority becomes an offence. The increased controls will have no impact on most hospital and community pharmacists.

As Schedule 4 Controlled Drugs, benzodiazepines are not subject to the requirement for community pharmacies and publicly funded hospitals to keep a CD register (a requirement only for Schedule 2 drugs), but any person possessing or supplying CDs under the terms of a Home Office licence (which could include some private hospitals) should check with the Home Office (advice on legal changes, tel 020 7273 3474; enquiries in respect of production, supply and possession authorisations, tel 020 7273 2620; applications for and enquiries about import and export licences, tel 020 7273 3475).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal